<DOC>
	<DOCNO>NCT01659567</DOCNO>
	<brief_summary>This prospective observational study investigate predictive value virological response peginterferon/ribavirin treatment-naive patient chronic hepatitis C. Patients treat Pegasys ( peg-interferon alpha 2a ) Copegus ( ribavirin ) prescribe physician . Data collect 72 week .</brief_summary>
	<brief_title>An Observational Study Pegasys Copegus Treatment-Naive Patients With Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Adult patient , &gt; /=18 year age Diagnosis chronic hepatitis C infection Coinfection human immunodeficiency virus ( HIV ) and/or hepatitis B Patients previously treat peginterferon/ribavirin Participation another clinical study within 30 prior study start ML25544</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>